Dynasil Announces Filing for NASDAQ Capital Market Listing

Dynasil Corporation of America (OTCBB: DYSL) today announced that it has filed an application to list its common stock on the NASDAQ Capital Market.

“We believe the move to the NASDAQ Capital Market is the next logical step in the Company’s future growth and will enable us to increase our stock’s trading liquidity, broaden our shareholder base and raise our profile in the investment community,” said Craig T. Dunham, CEO of Dynasil. “With our recent successes and record earnings, we believe that now is the time to move to a larger exchange. As we move forward with our growth strategy, a NASDAQ audience will allow us to attract additional investors and improve shareholder value.”

The NASDAQ listing application is subject to review and approval by NASDAQ’s Listing Qualifications Department for compliance with all NASDAQ Capital Market Standards. While the Company intends to satisfy all of NASDAQ’s requirements for initial listing, no assurance can be given that its application will be approved. The Company’s common stock will continue to trade on the OTC Bulletin Board under its current symbol, DYSL.OB, during the NASDAQ review process.

On October 1, 2010, Dynasil relocated its corporate headquarters from New Jersey to Watertown, Massachusetts. “Through acquisitions over the last five years, the Boston area now represents our largest concentration of commercial and research operations,” said Craig T. Dunham, Dynasil CEO. “We are focused on continued organic growth along with commercialization of new technologies from RMD Research for nuclear detection as well as additional acquisitions.”

About Dynasil: Dynasil Corporation of America (OTCBB: DYSL), is a provider of technology, products, services and solutions aimed at making the world safer and healthier. The company supplies a broad range of customers by serving their specific needs in the medical, industrial, and homeland security/defense markets. The Company has operations in Massachusetts, New Jersey, New York and the UK.

This news release may contain forward-looking statements usually containing the words "believe," "expect," “plan,” “target,” “intend” or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act. Statements regarding future results of operations, projections, and expectations, including those relating to the listing of the Company’s common stock on the NASDAQ Capital Market and the future growth of the Company, involve certain risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the factors detailed in the Company's Annual Report or Form 10-K, Quarterly Reports on Form 10-Q, as well as in the Company's other Securities and Exchange Commission filings, continuation of existing market conditions and demand for our products.